| Product Code: ETC9940782 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Chronic Disease Management Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Chronic Disease Management Market - Industry Life Cycle |
3.4 United Kingdom (UK) Chronic Disease Management Market - Porter's Five Forces |
3.5 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume Share, By Solution Type, 2021 & 2031F |
3.7 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.8 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.9 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Chronic Disease Management Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK population |
4.2.2 Government initiatives and policies promoting chronic disease management |
4.2.3 Technological advancements in healthcare leading to better disease management solutions |
4.3 Market Restraints |
4.3.1 High costs associated with chronic disease management solutions |
4.3.2 Lack of awareness and education about chronic diseases among the population |
4.3.3 Limited access to healthcare services in certain regions of the UK |
5 United Kingdom (UK) Chronic Disease Management Market Trends |
6 United Kingdom (UK) Chronic Disease Management Market, By Types |
6.1 United Kingdom (UK) Chronic Disease Management Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Solution, 2021- 2031F |
6.1.4 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United Kingdom (UK) Chronic Disease Management Market, By Solution Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By On-Premise Solution, 2021- 2031F |
6.2.3 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Cloud-Based Solution, 2021- 2031F |
6.2.4 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Web-Based, 2021- 2031F |
6.3 United Kingdom (UK) Chronic Disease Management Market, By Service Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Educational Service, 2021- 2031F |
6.3.3 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Implementation Service, 2021- 2031F |
6.3.4 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Consulting Service, 2021- 2031F |
6.3.5 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Chronic Disease Management Market, By Disease Type |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Cardiovascular Diseases (CVD), 2021- 2031F |
6.4.3 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.4 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Chronic Obstructive Pulmonary Disorders (COPD), 2021- 2031F |
6.4.5 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.4.6 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Asthma, 2021- 2031F |
6.4.7 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Cancer, 2021- 2031F |
6.5 United Kingdom (UK) Chronic Disease Management Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.5.3 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Healthcare Payers, 2021- 2031F |
6.5.4 United Kingdom (UK) Chronic Disease Management Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Chronic Disease Management Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Chronic Disease Management Market Export to Major Countries |
7.2 United Kingdom (UK) Chronic Disease Management Market Imports from Major Countries |
8 United Kingdom (UK) Chronic Disease Management Market Key Performance Indicators |
8.1 Patient engagement rates in chronic disease management programs |
8.2 Adoption rates of digital health technologies for disease management |
8.3 Percentage of patients achieving disease management goals |
8.4 Average length of hospital stays for chronic disease management |
8.5 Rate of readmissions for chronic disease patients |
9 United Kingdom (UK) Chronic Disease Management Market - Opportunity Assessment |
9.1 United Kingdom (UK) Chronic Disease Management Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Chronic Disease Management Market Opportunity Assessment, By Solution Type, 2021 & 2031F |
9.3 United Kingdom (UK) Chronic Disease Management Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.4 United Kingdom (UK) Chronic Disease Management Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.5 United Kingdom (UK) Chronic Disease Management Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Chronic Disease Management Market - Competitive Landscape |
10.1 United Kingdom (UK) Chronic Disease Management Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Chronic Disease Management Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here